Authors: Tsavaris, N Kosmas, C Vadiaka, M Kontos, A Katsorida, M Dimitrakopoulos, A Zerai, A Koufos, C

Citation: N. Tsavaris et al., Efficacy of ondansentron treatment for acute emesis with different dosing schedules 8 vs 32 mg. A randomized study, J EXP CL C, 20(1), 2001, pp. 29-34

Authors: Tsavaris, N Skarlos, D Bacoyiannis, C Aravantinos, G Kosmas, C Retalis, G Panopoulos, C Vadiaka, M Dimitrakopoulos, A Kostantinidis, K Mitropoulos, D Bougas, D Pantazopoulos, D Kosmidis, P

Citation: N. Tsavaris et al., Combined treatment with low-dose interferon plus vinblastine is associatedwith less toxicity than conventional interferon monotherapy in patients with metastatic renal cell carcinoma, J INTERF CY, 20(8), 2000, pp. 685-690

Authors: Dimitrakopoulos, A Takou, A Haida, A Molangeli, S Gialeraki, A Kordossis, T

Citation: A. Dimitrakopoulos et al., The prevalence of hepatitis B and C in HIV-positive Greek patients: Relationship to survival of deceased AIDS patients, J INFECTION, 40(2), 2000, pp. 127-131

Authors: Tsavaris, NB Koufos, C Katsikas, M Dimitrakopoulos, A Athanasiou, E Linardaki, G

Citation: Nb. Tsavaris et al., Antiemetic prophylaxis with ondansetron and methylprednisolone vs metoclopramide and methylprednisolone in mild and moderately emetogenic chemotherapy, J PAIN SYMP, 18(3), 1999, pp. 218-222